Navigation Links
Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
Date:5/3/2012

nts undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.

Forward-Looking Statements

This press release contains forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, which are subject to the "safe harbor" created by those sections. These statements include, but are not limited to, the number of orphan GPCRs that Omeros expects to unlock; the potential indications of the orphans GPCRs unlocked by Omeros; Omeros' patent objective for each unlocked orphan GPCR; and that Omeros may have capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Forward-looking statements are based on management's beliefs and assumptions and on information available to management only as of the date of this press release. Omeros' actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors described under the heading "Risk Factors" in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 15, 2012. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and the Company assumes no obligation to update these forward-looking statements publicly, even if new information becomes available in the future.

 


'/>"/>
SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
2. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
3. Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
4. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
5. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
6. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
7. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
8. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
9. Daniel K. Spiegelman Elected to Board of Directors of Omeros
10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
11. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... 2013 Life Science Firm of the Year by the Tech ... honored at the TCM,s 25 th Annual Tech Awards ... Tech Awards Celebration recognizes the leaders and innovators in the ... and the surrounding regions. "We are ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de 2013 /PRNewswire/ ... destacado desarrollador y fabricante de herramientas de precisión ... y tratamiento de la enfermedad vascular periférica y ... ADVISE ( Ad enosine V asodilator ... II durante la sesión de ensayo clínico hot ...
(Date:5/23/2013)... , May 23, 2013 Neurocrine Biosciences, Inc. (Nasdaq: ... Gorman , President and Chief Executive Officer of Neurocrine ... Annual dbAccess Health Care Conference in Boston.   ... at 11:20 a.m. Eastern Time / 8:20 a.m. Pacific Time.  ... the Company,s website at http://www.neurocrine.com . ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... 2 "A two-year,survival rate of more ... anaplastic,astrocytoma suggests a breakthrough in this devastating ... Neuro-Oncologist and Coordinating,Investigator of the Phase IIb ... or refractory high-grade glioma, while presenting the,data ...
... American Transplant Congress in Toronto, MIAMI, June ... in,the Departments of Surgery and Pathology at the ... have corroborated the value of,monitoring cell- mediated immunity ... a regular laboratory assay of cell function,(ImmuKnow(R)/Cylex). Their ...
Cached Medicine Technology:Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 2Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 3Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 4University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 2University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 3University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 4
(Date:5/23/2013)... 2013 Vegas Hotel Escapes, the ... announce all new vacation packages for the upcoming ... Las Vegas for this patriotic holiday will be ... to VegasHotelEscapes.com's new special pricing available on VegasHotelEscapes.com's ... it guarantees the lowest prices possible on vacation ...
(Date:5/23/2013)... New Jersey (PRWEB) May 23, 2013 ... Americans suffering from irritable bowel syndrome (IBS), the food ... on your holiday fun. , “While hot dogs and ... plate during the warm weather months, IBS sufferers often ... says Deborah Sokol, MD, a gastroenterologist with Lourdes Medical ...
(Date:5/23/2013)... 23, 2013 Onlinefitnessreview.com recently published a ... to determine what makes this diet work and how ... highlights three main components of the program: eliminating foods ... mindset and the personal motivation that is needed to ... days to keep the metabolism rate in top gear. ...
(Date:5/23/2013)... Mann HealthDay Reporter , , THURSDAY, May 23 ... take to help treat hip and knee osteoarthritis may ... for developing glaucoma, a small new study of older ... an increase of intraocular pressure (IOP) or pressure inside ... leading causes of blindness. In the ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Memorial Day ... , Chaplains have been a part of the U.S. ... Day, like those preceding it, these men and women ... the United States of America. As veterans transition ... their migration to the workplace chaplaincy world. , ...
Breaking Medicine News(10 mins):Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 3Health News:Onlinefitnessreview.com Publishes 7 Day Belly Blast Diet Review 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 3
... affect psychological well-being, , FRIDAY, Sept. 25 (HealthDay News) -- ... lose IQ points. , The good news is that it ... at least one expert believes that part of the reason ... in the United States and elsewhere. , That,s the view ...
... Life ... with one of its Northwest Division President,s Awards on Monday, Sept. 21. , ... Kirkland, WA (PRWEB) September 25, 2009 -- ... Care Center of Kirkland , with one of its Northwest Division President,s Awards on Monday, ...
... ... portable oxygen machine from Invacare with an amazing 1.8 liters per minute ... oxygen output. Now, oxygen therapy patients requiring large doses of oxygen can ... mobility and freedom. This new portable concentrator is now available for online ...
... researchers say , THURSDAY, Sept. 24 (HealthDay News) -- ... with carpal tunnel syndrome who don,t have severe nerve ... included 44 patients who had surgery and 52 patients ... ultrasound. A year after treatment, the patients, hand function ...
... CA SEPTEMER 24, 2009 Results from a ... combination of giving patients clopidogrel, a blood thinner commonly ... such as omeprazole, known as proton pump inhibitors (PPIs), ... studies had suggested. The results were presented at the ...
... BEDFORD, Mass., Sept. 24 ... HOLX ), a leading developer, manufacturer and supplier ... dedicated to serving the healthcare needs of women, today ... Clinical Excellence (NICE), in its updated guidance for hysteroscopic ...
Cached Medicine News:Health News:Spanking May Lower Kids' IQs 2Health News:Spanking May Lower Kids' IQs 3Health News:Local Nursing Home Leader Receives Life Care's Northwest Division President's Award 2Health News:New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 2Health News:New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 3Health News:New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 4Health News:New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 5Health News:Surgery Best for Carpal Tunnel Syndrome 2Health News:Surgery Best for Carpal Tunnel Syndrome 3Health News:Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine 2Health News:New U.K. NICE Guidance Supports Use of Hologic's Adiana(R) Permanent Contraception System 2Health News:New U.K. NICE Guidance Supports Use of Hologic's Adiana(R) Permanent Contraception System 3Health News:New U.K. NICE Guidance Supports Use of Hologic's Adiana(R) Permanent Contraception System 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: